Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. - Wikidata - awgldk - TriplyDB

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

http://www.wikidata.org/entity/Q35847602

about

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms Late effects of blood and marrow transplantation.Health-related quality of life in adolescents at the time of diagnosis with osteosarcoma or acute myeloid leukemia.Late cardiovascular complications after hematopoietic cell transplantation.Long-term consequences of hematopoietic stem cell transplantation: current state of the science.Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901 Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study.Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage a Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Subsequent malignant neoplasms after hematopoietic cell transplantation.Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pedia Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells Using three legacy measures to develop a health-related quality of life tool for young adult survivors of childhood cancer The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts' potential.Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.How can hematopoietic cell transplant centers and referring physicians help each other during long-term follow-up?Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.Concerns of stem cell transplant patients during routine ambulatory assessment Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patient.Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation.

P2860

Q24201885-98FC412D-46EE-4B9B-B1B3-16C0F295A7A7 Q24235485-A4FE8D41-3AC3-4393-AF6C-A358A1C52350 Q24235563-95C18A37-5514-479F-97D1-637758075F7A Q24242466-3D39431F-DD3B-456D-8620-A8DF3EEA4581 Q29248394-E7654045-232E-404C-9E3D-2E4F1808E21C Q33574136-D85A65FE-5CFF-4633-B8E0-677CB2C235E6 Q33598078-DF683FDE-F173-45AE-836F-6D30C94DD15C Q33605306-1A7A30D0-0762-47AD-8299-A5E1E95EF6B6 Q33705877-BAF78E31-6655-4EC1-BCE8-C62AB62BF0C2 Q33710708-54949142-7EE1-452B-86B6-B63ACF164454 Q33754654-D8ACF39F-E65C-4BA7-884C-9C502EDA4462 Q34091836-0F555F63-69DA-4A97-8B6C-60EE206FD9F5 Q34102941-F3CF4406-1D85-4B66-AE41-6B4565C85AFF Q34297698-C0A4D3CB-EFEA-40E4-87F6-81A28985EE28 Q34369800-D7F7907D-F8A2-4E5F-B599-A3EEA5300B73 Q34422543-451B1D56-88D2-455E-975C-60D44EA8CD49 Q34548829-8F1D66CF-9119-4F5A-B253-FCD45EE1D2D2 Q35100217-5CD723B8-9168-4327-BD6F-36A84B5EE2FF Q35100332-FE56C377-736F-44FC-9511-B2BCD76948A0 Q35117677-CE46A324-D32C-4D92-88BC-DC7EC89A1E3D Q35184667-D478A32D-2481-46EB-AB77-3195A70DF6E3 Q35223893-262E7D1A-629E-4CCB-88D5-17F6C4BD88EF Q35223947-6640B66C-7261-47FB-B13F-CBA53114064B Q35327266-721B8DBF-C49F-4389-8093-CA770FC31DFC Q35525461-6C6FDEF6-B96D-4BAF-89CC-F3168C4B754A Q35549037-F7EFA62D-30CE-4804-99C6-32EF0757D0DF Q35604039-A1CF323B-03FC-4430-9427-944171433BD5 Q35678455-2C35A285-4C61-4DC9-91B4-E7B6C2265EA3 Q35679620-9087BAAE-4640-4545-AA0E-1173DCBDBE98 Q35757247-EFD1807D-02EF-4A40-A63A-DCC9FF54309C Q35762578-B5C66279-EFF8-4179-AA41-979B064687FD Q35848553-F1A40D61-D683-4597-9B54-AF35645F173B Q35895050-1AB04020-9398-4F29-90F5-501FBC147816 Q36102990-D2D77A5A-FA93-4F7A-9420-BEB0387B117C Q36155132-8F399454-5E58-490F-95BA-B92DAB49C4E7 Q36270130-6057CF43-B716-4250-AE06-86DE266CA6B0 Q36440055-5463B57A-D9D7-4BD6-80C2-9A8418D99A68 Q36520769-34116452-DA16-4452-983E-189118F9806F Q36612560-30D4DA8C-68C7-4862-AA98-A5A3F52D8AEF Q36678516-AF135423-7B3E-4785-9A96-462110437FEC

P2860

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

http://www.wikidata.org/entity/Q35847602

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Late mortality in survivors of ...... row Transplant Survivor Study.

@ast

Late mortality in survivors of ...... row Transplant Survivor Study.

@en

type

label

Late mortality in survivors of ...... row Transplant Survivor Study.

@ast

Late mortality in survivors of ...... row Transplant Survivor Study.

@en

prefLabel

Late mortality in survivors of ...... row Transplant Survivor Study.

@ast

Late mortality in survivors of ...... row Transplant Survivor Study.

@en

P1433

Q35847602-7E72728F-5438-4F1F-8AFF-9EC07F92FC75

P1476

Q35847602-55D702AF-78B1-495B-8081-12FDC4F1A8C0

P2093

Q35847602-0FBBFA19-CBFD-400A-B740-FC26CB6DFC64

Q35847602-1FE0158A-71CB-420D-90BD-E7FB7B738BA9

Q35847602-20ED028E-6006-4ECC-B93B-3485F215C1A8

Q35847602-2DE2AC31-1ED0-43BE-87DA-0B1672D5BBE0

Q35847602-387BE0A2-E0BB-4503-992A-E4DFA61EBE3B

Q35847602-39AC7844-8B7F-4427-864C-201F99E46A74

Q35847602-47305AB4-8FB6-4799-8D14-64E79F715475

Q35847602-56E0BA13-EB24-45FB-809F-B6AB61924F3A

Q35847602-627F6114-F78D-4994-AD2A-ED048300E028

Q35847602-83FFB2CC-4BAE-465C-9D72-E82AE650F385

P2860

Q35847602-0A52BC0D-8F6B-4881-A84C-77CE7D2C317F

Q35847602-0D14F680-8540-4FD9-8DD8-0F32C5BC5880

Q35847602-15E62C93-F32A-4AD0-AF34-6E4A47735572

Q35847602-21D47A1C-1BDF-4939-862D-4E8302C333DB

Q35847602-22B90D88-FA3B-456D-AAB1-12E7AE891DF4

Q35847602-26232478-A597-4CE0-8565-891A864ABD66

Q35847602-3FAB07E8-39B8-4071-A9D6-213E2194C9B0

Q35847602-4B60410A-4778-441E-BA31-670B0B31DDE8

Q35847602-4D7CE4DC-747B-4D46-8B94-DA26CF4A8016

Q35847602-50193929-F966-4C7D-9A31-32CA2326DCB1

P304

Q35847602-F1C802D7-E021-4B74-B54C-935DCAFD9947

P31

Q35847602-C51CED16-E373-40AD-A9DC-E128B439BAE1

P356

Q35847602-D760A019-37E9-4B49-8459-4FFF18F6FB8E

P407

Q35847602-2CCB97FB-30EA-4C16-9BFA-7057F3853072

P433

Q35847602-3E9D42C9-489B-4A3B-9CEF-EA245F920A75

P478

Q35847602-B00EE888-30EB-46E1-BD2A-3D256C16B989

P577

Q35847602-51F60557-F360-4F1F-AADA-AB9CB2B8CEEA

P5875

Q35847602-B6C1DB10-A039-4998-952D-B24CF77D7921

P698

Q35847602-41B9E3E6-AD4A-44C4-93D5-D4C1538965A1

P921

Q35847602-2EE8DB57-6F8F-4401-B7A4-A038C6813F3F

P932

Q35847602-C20F09B4-DFCC-4590-B5E8-DAB860BAF9A7

P356

BLOOD-2005-01-0035

P1433

P1476

Late mortality in survivors of ...... row Transplant Survivor Study.

@en

P2093

Andrea Carter

http://www.w3.org/2001/XMLSchema#string

Anthony Stein

http://www.w3.org/2001/XMLSchema#string

Auayporn Nademanee

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

Henry Fung

http://www.w3.org/2001/XMLSchema#string

James G Gurney

http://www.w3.org/2001/XMLSchema#string

K Scott Baker

http://www.w3.org/2001/XMLSchema#string

Leslie L Robison

http://www.w3.org/2001/XMLSchema#string

Liton Francisco

http://www.w3.org/2001/XMLSchema#string

Marcia Grant

http://www.w3.org/2001/XMLSchema#string

P2860

Leukemia following Hodgkin's disease

Cancer statistics, 2004

Therapy-related acute leukemia.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Pulmonary toxicity of antineoplastic therapy.

Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.

Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma.

Malignant neoplasms following bone marrow transplantation.

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.

P304

4215-4222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-01-0035

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8030627

http://www.w3.org/2001/XMLSchema#string

P698

15701723

http://www.w3.org/2001/XMLSchema#string

P921

P932

1895040

http://www.w3.org/2001/XMLSchema#string